Drug
Glycerylphosphorylcholine clinical trials
Also written Choline alfoscerate.
- studies test it
- 10
- open now
- 2
- in phase 3
- 2
- first study started
- 2010
Keep track of what changes. Save the Glycerylphosphorylcholine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
10 studies that test it; most in 2021 (2)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 1
- Phase 3
- 2
- Phase 4
- 5
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 6
Chong Kun Dang Pharmaceutical (2) · Samsung Medical Center (1) · Azienda Ospedaliero-Universitaria Careggi (1) · Seoul National University Bundang Hospital (1) · Seoul National University Hospital (1) · Clinical Institute of the Brain, Russia (1) · Northern Illinois University (1) · Daewoong Bio Inc. (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Glycerylphosphorylcholine is read from its arms, and is right about nine times in ten.
Testing it · 10
- Acute Effects of Alpha-glycerylphosphorylcholine (A-GPC) on Lower Body Muscular Performance.Not yet recruitingNot applicableNorthern Illinois UniversityNCT07397273Written as L-Alpha glycerylphosphorylcholine
- Efficacy and Safety of ChOline ALfoscerate in Patient With Mild to Moderate Alzheimer's DiseaseRecruitingPhase 4Daewoong Bio Inc.NCT05383183Written as Choline Alfoscerate 400mg
- Clinical Effectiveness of Choline Alphoscerate for Older Adults With Major Depression and Subjective Memory ComplaintsCompletedNot applicableSamsung Medical CenterNCT05257902Written as choline alphoscerate
- A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate in Vascular Cognitive Impairment PatientsStatus unknownPhase 4Chong Kun Dang PharmaceuticalNCT05050604Written as Choline Alfoscerate 400mg
- A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive ImpairmentStatus unknownPhase 4Chong Kun Dang PharmaceuticalNCT05041790Written as Choline Alfoscerate
- Choline Alphoscerate-Nimodipine in Vascular Cognitive ImpairmentCompletedPhase 2Azienda Ospedaliero-Universitaria CareggiNCT03228498Written as Choline alphoscerate
- The Effect of Choline Alfoscerate on Improvement of Cognitive Function in Elderly Patients With DiabetesCompletedPhase 3Seoul National University Bundang HospitalNCT03249259Written as Choline alfoscerate
- A Clinical Trial for an Evaluation of Choline Alfoscerate and Donepezil for Cognitive Improvements of Patients With Cerebrovascular Injury in Alzheimer PatientsStatus unknownPhase 4Daewoong Pharmaceutical Co. LTD.NCT02648906Written as Choline alfoscerate
- The Efficacy of Gliatiline® on Post-stroke Patients With Vascular Cognitive Impairment no DementiaCompletedPhase 4Seoul National University HospitalNCT01363648Written as choline alfoscerate
- Navigation Brain Stimulation for Evaluation of the Neuroprotective Drug Efficiency in Patients After Ischemic Stroke.CompletedPhase 3Clinical Institute of the Brain, RussiaNCT01388738Written as L-Alpha glycerylphosphorylcholine
As the comparator · 1 — what is tested is compared with Glycerylphosphorylcholine
Codes
What other systems call Glycerylphosphorylcholine · ClinicalTrials.gg INT007571
- MeSH (NLM) D005997GlycerylphosphorylcholineOne source NLM
- UNII (FDA) 60M22SGW66CHOLINE ALFOSCERATEConfirmed FDA, NLM
- RxNorm 4918One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D005997 | Glycerylphosphorylcholine | One source NLM |
| UNII (FDA) | 60M22SGW66 | CHOLINE ALFOSCERATE | Confirmed FDA, NLM |
| RxNorm | 4918 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.